Baylor College of Medicine at Texas Childrens Hospital
I am a physician-scientist trained in Pediatric Critical Care Medicine, dedicated to reducing morbidity and mortality in critically ill patients. My clinical and research efforts focus on improving treatment strategies for coagulopathy in critical illness, particularly sepsis-induced coagulopathy (SIC).My current translational research focuses on how abnormalities in clot structure and function, driven by immune dysregulation, contribute to morbidity in critical illness. Using ex vivo and translational approaches, I investigate how clot formation, breakdown, porosity, and permeability relate to inflammatory signatures in sepsis.
Aberrant Ex Vivo Clot Characteristics in a Swine Model of E coli Sepsis-Induced Coagulopathy
Sunday, March 22, 2026
2:30 PM - 3:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Interleukin-1β Interaction With Fibrin(ogen) May Alter Ex Vivo Clot Characteristics in Sepsis
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Pediatric Case Series of Endobronchial Valve Placement to Mitigate Persistent Air Leak on ECMO
Tuesday, March 24, 2026
12:30 PM - 1:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
